SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193805-22-001295
Filing Date
2022-09-20
Accepted
2022-09-20 20:30:58
Documents
2
Period of Report
2022-09-16

Document Format Files

Seq Description Document Type Size
1 e621936_3-lt.html 3  
1 e621936_3-lt.xml 3 3893
2 e621936_ex99.htm EX-99 4258
  Complete submission text file 0001193805-22-001295.txt   10653
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017 2125511600
Deerfield Mgmt L.P. (Reporting) CIK: 0001010823 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36510 | Film No.: 221254855

Mailing Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010 212-551-1600
DEERFIELD PARTNERS, L.P. (Reporting) CIK: 0001301041 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-36510 | Film No.: 221254856

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Issuer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations